Verge, Charles F.
UNSW Sydney · Sydney Children's Hospital
8 papers on CoChatORCID 0000-0001-9343-258X
Most cited papers
- Verified
Prediction of type I diabetes in first-degree relatives using a combination of insulin, GAD, and ICA512bdc/IA-2 autoantibodies
Verge, C. F., Gianani, R., Kawasaki, E., Yu, L., Pietropaolo, M., Chase, H. P., Eisenbarth, G. S., & Jackson, R. A. (1996) · Diabetes
Diabetes and associated disordersDiabetes Management and Research
Cited by 827
- Verified
Mutant P450 oxidoreductase causes disordered steroidogenesis with and without Antley-Bixler syndrome
Flück, C. E., Tajima, T., Pandey, A. V., Arlt, W., Okuhara, K., Verge, C. F., Jabs, E. W., Mendonça, B. B., Fujieda, K., & Miller, W. L. (2004) · Nature Genetics
Sexual Differentiation and DisordersAdrenal Hormones and Disorders
Cited by 509
- Verified
Combined use of autoantibodies (IA-2 autoantibody, GAD autoantibody, insulin autoantibody, cytoplasmic islet cell antibodies) in type 1 diabetes: Combinatorial Islet Autoantibody Workshop
Verge, C. F., Stenger, D., Bonifacio, E., Colman, P. G., Pilcher, C., Bingley, P. J., & Eisenbarth, G. S. (1998) · Diabetes
Diabetes and associated disordersDiabetes Management and Research
Cited by 420
- Verified
Mutations of the Thyroid Hormone Transporter MCT8 Cause Prenatal Brain Damage and Persistent Hypomyelination
López-Espíndola, D., Morales-Bastos, C., Grijota-Martínez, C., Liao, X.-H., Lev, D., Sugo, E., Verge, C. F., Refetoff, S., Bernal, J., & Guadaño-Ferraz, A. (2014) · The Journal of Clinical Endocrinology & Metabolism
Thyroid Disorders and TreatmentsGenetics and Neurodevelopmental Disorders
Cited by 155
- Verified
Diiodothyropropionic acid (DITPA) in the treatment of MCT8 deficiency
Verge, C. F., Konrad, D., Cohen, M., Di Cosmo, C., Dumitrescu, A. M., Marcinkowski, T., Hameed, S., Hamilton, J., Weiss, R. E., & Refetoff, S. (2012) · The Journal of Clinical Endocrinology & Metabolism
Thyroid Disorders and TreatmentsMetabolism and Genetic Disorders
Cited by 134
- Verified
Setmelanotide in patients aged 2–5 years with rare MC4R pathway-associated obesity (VENTURE): a 1 year, open-label, multicenter, phase 3 trial
Argente, J., Verge, C. F., Okorie, U., Fennoy, I., Kelsey, M. M., Cokkinias, C., Scimia, C., Lee, H.-M., & Farooqi, I. S. (2025) · The Lancet Diabetes & Endocrinology
Regulation of Appetite and ObesityPharmacology and Obesity Treatment
Cited by 55
- Verified
Peak OGTT glucose is associated with lower lung function in young children with cystic fibrosis
Prentice, B. J., Chelliah, A., Ooi, C. Y., Hameed, S., Verge, C. F., Plush, L., & Widger, J. (2020) · Journal of Cystic Fibrosis
Cystic Fibrosis Research AdvancesDiabetes Management and Research
Cited by 39
- Verified
Hypothalamic-pituitary-adrenal axis recovery following prolonged prednisolone therapy in infants
Mendoza-Cruz, A. C., Wargon, O., Adams, S., Tran, H., & Verge, C. F. (2013) · The Journal of Clinical Endocrinology & Metabolism
Adrenal Hormones and DisordersStress Responses and Cortisol
Cited by 16
Go further with a free account
Verify every reference, keep papers in a library, and ask questions across them.
Sign up - it is free